You are here

SAGE Open Medicine: Vascularized Composite Allotransplantation

SAGE Open Medicine: Vascularized Composite Allotransplantation


Editor
Gerald Brandacher, MD Johns Hopkins School of Medicine, Baltimore, Maryland, USA

ISSN: 00000002
Vascularized Composite Allotransplantation, a SAGE Open Medicine publication, is the first multidisciplinary, peer-reviewed, international journal to exclusively focus on this new discipline. Vascularized Composite Allotransplantation is an emerging new era in transplant medicine and has become a viable reconstructive option for patients with extensive tissue defects and severe dysfunctions.

VCA publishes several types of manuscripts including Original Articles, Clinical Studies and Case Reports, Reviews, Commentaries, and highlights from meetings devoted to Vascularized Composite Allotransplantation. Special issues dedicated to particular types of vascularized composite allografts are also anticipated.

It is the purpose of the American Society for Reconstructive Transplantation (ASRT) to provide a platform for the advancement of education, science and practice of composite tissue allotransplantation (CTA) as relevant to reconstructive and transplant surgery.

Introducing VCA

Vascularized Composite Allotransplantation is an emerging new era in transplant medicine and has become a viable reconstructive option for patients with extensive tissue defects and severe dysfunctions. Advances in microsurgical techniques, transplant immunology and the development of novel immunosuppressive agents have enabled the realization of such novel transplants. Over the past decade, a rapidly growing number of face and upper extremity transplantations have been performed worldwide with highly encouraging outcomes.

VCA is the first multidisciplinary, peer-reviewed, international journal to exclusively focus on this new discipline. The content of this journal is directed towards both basic scientists and clinicians, with the aim of delivering the most complete and reliable source of information on current developments and advances in this novel field of transplantation. The journal welcomes high-quality scientific articles on a broad range of topics including organ/tissue preservation, ischemia reperfusion injury, mechanisms of skin rejection, immune regulation and tolerance induction, experimental immunosuppression and immune monitoring, nerve regeneration and cortical reintegration, as well as surgical techniques, and clinical trials and protocols.

VCA publishes several types of manuscripts including Original Articles, Clinical Studies and Case Reports, Reviews, Commentaries, and highlights from meetings devoted to Vascularized Composite Allotransplantation. Special issues dedicated to particular types of vascularized composite allografts are also anticipated. We are welcoming authors, reviewers and readers to join this exciting new venture of VCA.

Editor-in- Chief
Gerald Brandacher, MD Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Co-Editors-in-Chief
W.P. Andrew Lee, MD Johns Hopkins University School of Medicine, Baltimore, MD, USA
David H. Sachs, MD Harvard Medical School, Massachusetts General Hospital, USA
Associate Editors
Jean-Michel Dubernard, MD Hôpital Edouard Herriot, HCL, Lyon, France
L. Scott Levin, MD University of Pennsylvania, Philadelphia, PA, USA
Raimund Margreiter, MD Innsbruck Medical University, Innsbruck, Austria
Bohdan Pomahac, MD Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Stefan Schneeberger, MD Innsbruck Medical University, Innsbruck, Austria
Maria Siemionow, MD, PhD University of Illinois at Chicago, Chicago, IL, USA
Editorial Board
Kodi Azari, MD David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Rolf N. Barth, MD University of Maryland, Baltimore, MD, USA
Warren C. Breidenbach III, MD The University of Arizona, Tucson, AZ, USA
Peter Butler, MD University College London, London, UK
Linda C. Cendales, MD Duke University, Durham, NC, USA
Daniel J. Ceradini, MD, PhD New York University, Langone Medical Center, New York, NY, USA
Curtis L. Cetrulo Jr., MD Massachusetts General Hospital, Harvard Medical School Boston, MA, USA
Eric Elster, MD, CAPT MC USN Uniformed Services University, Bethesda, MD, USA
Scott H. Frey, PhD University of Missouri, Columbia, MO, USA
Vijay S. Gorantla, MD, PhD Wake Forest University, Winston-Salem, NC, USA
Shehan Hettiaratchy, MD Imperial College, London, UK
Suzanne T. Ildstad Institute for Cellular Therapeutics, Jewish Hospital, Louisville, KY, USA
Jerzy Jablecki, MD St Hedwig of Silesia Hospital, Trzebnica, Poland
Christina Kaufman, PhD University of Louisville, Louisville, KY, USA
Yur-Ren Kuo, MD, PhD Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Josef M. Kurtz, PhD Harvard Medical School, Boston, MA, USA
David Mathes, MD University of Colorado, Denver, CO, USA
Sue V. McDiarmid, MD David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Steven L. Moran, MD Mayo Clinic, Rochester, MN, USA
Palmina Petruzzo, MD University of Cagliari, Cagliari, Italy
Eduardo D. Rodriguez, MD, DDS NYU Langone Medical Center, New York, NY, USA
Jaimie T. Shores, MD Johns Hopkins University School of Medicine, Baltimore, MD, USA
Fu-Chan Wei, MD, PhD Chang Gung University, Taoyuan, Taiwan
Jason Wertheim, MD, PhD Northwestern University, Chicago, IL, USA
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • Directory of Open Access Journals (DOAJ)
  • Scopus